Summary
- Current Price
- As of today, SPRY price is $6.10, up +0.83% on
- Current Price All-Time High
- SPRY price is currently -90.38% below its historical high of $63.41 set on
- Market Cap
- SPRY current market cap is $606M, down -61.20% year-over-year
- Revenue
- SPRY current annual revenue is $84.28M, down -5.46% year-over-year
- Next Earnings
- The next earnings release for SPRY is on
Profile
| Metric | Value |
|---|---|
| Full Name | ARS Pharmaceuticals, Inc. |
| Ticker | NASDAQ: SPRY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ars-pharma.com |
| Employees | 155 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $6.10 | |
| Price, 1D Change | +0.83% | |
| $606M | ||
| - | ||
| - | ||
| 1.39 | ||
| $84.28M | ||
| Revenue, 1Y Change | -5.46% | |
| -$1.74 | ||
| EPS, 1Y Change | -2,325.22% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | SBTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.74 | ||
| EPS Estimate | -$1.72 | N/A |
| EPS Est. Change | +1.03% | N/A |
| $84.28M | ||
| Revenue Estimate | $139.84M | N/A |
| Revenue Est. Change | +65.93% | N/A |
| Current Price | $6.10 | |
| Price Target | $27.00 | - |
| Price Tgt. Change | +342.62% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.56 | $0.08 | +113.95% | |
| -$1.80 | -$1.74 | +3.45% | |
| -$1.72 | N/A | +1.03% | |
| -$0.94 | N/A | +45.72% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $18.48M | $89.15M | +382.41% | |
| $81.68M | $84.28M | +3.18% | |
| $139.84M | N/A | +65.93% | |
| $245.77M | N/A | +191.62% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $6.10 | |
| $8.81 | ||
| $7.69 | ||
| $8.91 | ||
| $7.11 | ||
| -$0.50 | ||
| 1.39 | ||
| $0.44 | ||
| 44.22 | ||
| 90.36% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $84.28M | ||
| -$1.74 | ||
| $63.86M | ||
| 75.77% | ||
| -$179.45M | ||
| -212.92% | ||
| -$171.30M | ||
| -203.25% | ||
| -$178.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.85 | ||
| 7.28 | ||
| 7.06 | ||
| - | ||
| 1 | ||
| -0.21 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 6.12 | ||
| 9.88 | ||
| -2.49 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $114.26M | ||
| $244.99M | ||
| $327.65M | ||
| $284.90M | ||
| $213.39M | ||
| $39.15M | ||
| $96.96M | ||
| $588.00K | ||
| $5.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $255.58M | ||
| $243.30M | ||
| $20.42M | ||
| $0.00 | ||
| $1.37M | ||
| $0.00 | ||
| -$80.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$170.87M | ||
| $56.77M | ||
| $104.60M | ||
| $339.00K | ||
| -$171.21M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Leerink Partners | → | |
| Cantor Fitzgerald | → | |
| Roth Capital | ||
| Scotiabank | ||
| Raymond James | → | |
| Leerink Partners | → | |
| Cantor Fitzgerald | → | |
| Leerink Partners | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → |
Analyst sentiment
Institutional ownership
Screeners with SPRY
FAQ
- What is the ticker symbol for ARS Pharmaceuticals, Inc.?
- The ticker symbol for ARS Pharmaceuticals, Inc. is NASDAQ:SPRY
- Does ARS Pharmaceuticals, Inc. pay dividends?
- No, ARS Pharmaceuticals, Inc. does not pay dividends
- What sector is ARS Pharmaceuticals, Inc. in?
- ARS Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is ARS Pharmaceuticals, Inc. in?
- ARS Pharmaceuticals, Inc. is in the Biotechnology industry
- What country is ARS Pharmaceuticals, Inc. based in?
- ARS Pharmaceuticals, Inc. is headquartered in United States
- When did ARS Pharmaceuticals, Inc. go public?
- ARS Pharmaceuticals, Inc. initial public offering (IPO) was on December 4, 2020
- Is ARS Pharmaceuticals, Inc. in the S&P 500?
- No, ARS Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is ARS Pharmaceuticals, Inc. in the NASDAQ 100?
- No, ARS Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is ARS Pharmaceuticals, Inc. in the Dow Jones?
- No, ARS Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was ARS Pharmaceuticals, Inc. last earnings report?
- ARS Pharmaceuticals, Inc.'s most recent earnings report was on May 15, 2026
- When does ARS Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for ARS Pharmaceuticals, Inc. is August 13, 2026
Data Sources & References
- SPRY Official Website ars-pharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1671858/000119312526097478/0001193125-26-097478-index.htm
- SPRY Profile on Yahoo Finance finance.yahoo.com/quote/SPRY
- SPRY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/spry